Arkolith/Insider Trading/IDYA/Form 4

Throne Jason

Chief Legal OfficerIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Jun 27, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2024Option exercise(M)47K$7.01$330K63K
Jun 27, 2024Option exercise(M)6K$13.34$86K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 27, 2024Option exercise(M)6K—$041K
Jun 27, 2024Option exercise(M)47K—$01K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-24-000367) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML